Join us on campus this spring to meet our community of world-class innovators
As a reader of this newsletter, you’ll be familiar with many of the ways that the Imperial is using science to shape society for the better. But to fully experience the vitality, scope, and transformational potential of our innovative community, nothing beats meeting staff and students personally at our on-campus events.
At All You Can Innovate 2024in March, professionals in the life sciences, med tech and investment industries will have the chance to take part in a series of 1:1 corporate speed dates with academics and researchers, gain rapid knowledge about their research, and identify opportunities for collaborative translation and commercialisation.
In April, you are invited to the Grand Final of the Venture Catalyst Challenge 2024, our flagship competition for Imperial's world-class student entrepreneurs. Past participants in the Challenge include bioplastics company Notpla, water treatment company Puraffinity, and many others that like them have gone on to receive major investment and commercial success. You could be among the first to hear about the next big success story.
These events are an opportunity not only to learn about our innovations but to support us by providing expert insights from your sector that will help shape the development of our businesses and technologies – this is something we are hugely grateful for.
I hope to see you soon and look forward to talking with you in person. As always, please pass this on to colleagues who may also be interested.
A new iteration of the Imperial College Enterprise Fund (ICEF) has been launched to raise investment for innovative early-stage startups founded by staff, students and alumni.
EnAcuity, a spinout from Imperial and UCL, is developing AI-assisted imaging technology that can help surgeons identify functional differences in tissue as they carry out laparoscopic surgery.
Digistain, a company based on Imperial research, has gained clinical data to validate its diagnostic technology for breast cancer. The technique could help patients at low risk of recurrence to avoid unnecessary chemotherapy.
Over a dozen leading companies and research programmes from the Canadian biomanufacturing sector visited Imperial this week to learn about leading healthcare research.
As members of Horizon Europe, the UK's researchers have access to collaborate on major projects across the continent, including those tackling climate change and Alzheimer's disease.
With the proliferation of AI in our lives, how will we ensure that the legacy created now is not 'baked in' to prevent detrimental outcomes for future generations?
Hear from the CEO of FetchAI, the newest Imperial Business Partners I-X members, and learn more about the opportunities to engage with Imperial's AI community.
The Energy Futures Lab launches its new briefing paper on the decarbonisation of the electricity power system with a line up of expert panellists from academia and industry.
Stories of women in health, research and innovation. Sponsored by CoDiet, an EU-funded research project investigating the intricate relationship between diet and disease on an individual level.
Health and med tech businesses and investors will discover collaboration opportunities with startups and experts in translational research at this annual corporate speed dating event.
Hear from the teams that took part in Imperial's flagship student entrepreneurship competition and discover who will take home the £20,000 grand prize.
Join us at this afternoon event to learn about the new Incubator venue following its relocation last year, and hear from some of the exciting members and alumni
/ED%20-%20Branding/Imperial-enterprise-logo.png?upscale=true&width=400&upscale=true&name=Imperial-enterprise-logo.png){kind=logo}
